Despite being highly preventable and treatable, cardiovascular diseases (CVDs) impose the greatest burden compared to all other non-communicable conditions affecting Europe’s population. What’s more, CVDs have a much greater impact on the most socially and economically disadvantaged members of society. Better management and prevention of CVDs would therefore have a major impact on overall health. And this could help create more resilient and equitable health systems, which are better prepared to face future crises.
In «Towards a new normal: Why boosting cardiovascular health is critical», we explore how European countries can find ways to create more resilient and equitable health systems that deliver better health outcomes for all.
Improving the management and prevention of CVDs is a vital step forward for European health systems. One thing is clear: it will take collaboration across the whole health ecosystem to achieve this goal. In writing this paper, we’ve been very encouraged by the clear commitment we’ve seen from across the healthcare world to improve CVD management and prevention.
Please feel free to get in touch with us if you’d like to share your ideas on this topic or discuss your questions with one of our experts:
COVID-19 has caused an unprecedented shock to European healthcare systems, leaving no components unaffected. But impacts will be felt long after the pandemic subsides, creating new patterns of health demands that systems must prepare for. In such a complex environment, the challenge is knowing where to focus, and which...
The healthcare industry generates 30% of global data, but unlocking its value requires an optimal data and analytics model to drive growth and insights.
Making sure that the highest quality medicines consistently reach healthcare professionals, hospitals and patients is, of course, a key concern for biopharmaceutical companies. That vital role is played by Affiliate Quality (AQ) organisations that take responsibility for the oversight and control of distribution,...
The growth of digital health solutions has accelerated rapidly in the post-COVID era. But while there are plenty of innovative ideas in development, many companies are still struggling to move beyond promising pilots and into production at scale.
Managing Partner, Advisory and Consulting Leader, PwC Switzerland
Tel: +41 58 792 53 09
